- Home
- OSBC vs ALMS Comparison
OSBC vs ALMS Comparison
Compare OSBC & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSBC
- ALMS
- Stock Information
- Founded
- OSBC 1981
- ALMS 2021
- Country
- OSBC United States
- ALMS United States
- Employees
- OSBC N/A
- ALMS N/A
- Industry
- OSBC Major Banks
- ALMS
- Sector
- OSBC Finance
- ALMS
- Exchange
- OSBC Nasdaq
- ALMS NYSE
- Market Cap
- OSBC 722.5M
- ALMS 652.3M
- IPO Year
- OSBC N/A
- ALMS 2024
- Fundamental
- Price
- OSBC $18.46
- ALMS $8.85
- Analyst Decision
- OSBC Buy
- ALMS Strong Buy
- Analyst Count
- OSBC 4
- ALMS 6
- Target Price
- OSBC $18.75
- ALMS $29.60
- AVG Volume (30 Days)
- OSBC 319.4K
- ALMS 78.8K
- Earning Date
- OSBC 10-16-2024
- ALMS 11-13-2024
- Dividend Yield
- OSBC 1.30%
- ALMS N/A
- EPS Growth
- OSBC N/A
- ALMS N/A
- EPS
- OSBC 1.85
- ALMS N/A
- Revenue
- OSBC $264,069,000.00
- ALMS N/A
- Revenue This Year
- OSBC N/A
- ALMS N/A
- Revenue Next Year
- OSBC N/A
- ALMS N/A
- P/E Ratio
- OSBC $9.98
- ALMS N/A
- Revenue Growth
- OSBC N/A
- ALMS N/A
- 52 Week Low
- OSBC $13.00
- ALMS $8.23
- 52 Week High
- OSBC $18.86
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- OSBC 66.09
- ALMS N/A
- Support Level
- OSBC $16.01
- ALMS N/A
- Resistance Level
- OSBC $18.86
- ALMS N/A
- Average True Range (ATR)
- OSBC 0.53
- ALMS 0.00
- MACD
- OSBC 0.15
- ALMS 0.00
- Stochastic Oscillator
- OSBC 85.96
- ALMS 0.00
About OSBC Old Second Bancorp Inc.
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company's revenue consists of interest, commission, payments, and other income.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.